MDRD
|
|
175 × Scr-1.154 × age-0.203 × [0.742 if female]
|
CKD-EPI SCr
|
Female
|
SCr ≤ 0.7 mg/dL
|
144 × (Scr/0.7)-0.329 × 0.993age
|
SCr > 0.7 mg/dL
|
144 × (Scr/0.7)-1.209 × 0.993age
|
Male
|
SCr ≤ 0.9 mg/dL
|
141 × (Scr/0.9)-0.411 × 0.993age
|
SCr > 0.9 mg/dL
|
141 × (Scr/0.9)-1.209 × 0.993age
|
CKD-EPI SCysC
|
SCysC ≤ 0.8 mg/L
|
133 × (SCysC/0,8)-0.499 × 0.996age [×0.932 if female]
|
SCysC >0.8 mg/L
|
133 × (Scys/0,8)-1.328 × 0.996age [×0.932 if female]
|
CKD-EPI combined
|
Female
|
SCr ≤ 0.7 mg/dL and SCysC ≤ 0.8 mg/L
|
130 × (Scr/0.7)-0.248 × (SCysC/0.8)-0.375 × 0.995age
|
SCr ≤ 0.7 mg/dL and SCysC > 0.8 mg/L
|
130 × (Scr/0.7)-0.248 × (SCysC/0.8)-0.711 × 0.995age
|
SCr > 0.7 mg/dL and SCysC ≤ 0.8 mg/L
|
130 × (SCr/0.7)-0.601 × (SCysC/0.8)-0.375 × 0.995age
|
SCr >0.7 mg/dL and SCysC ≥ 0.8 mg/L
|
130 × (SCr/0.7)-0.601 × (SCysC/0.8)-0.711 × 0.995age
|
Male |
SCr ≤0.9 mg/dL and SCysC ≤ 0.8 mg/L
|
135 × (SCr/0.9)-0.207 × (SCysC/0.8)-0.375 × 0.995age
|
SCr ≤ 0.9 mg/dL and SCysC > 0.8 mg/L
|
135 × (SCr/0.9)-0.207 × (SCysC/0.8)-0.711 × 0.995age
|
SCr >0.9 mg/dL and SCysC ≤ 0.8 mg/L
|
135 × (SCr/0.9)-0.601 × (SCysC/0.8)-0.375 × 0.995age
|
SCr >0.9 mg/dL and SCysC > 0.8 mg/L |
135 × (SCr/0.7)-0.601 × (SCysC/0.8)-0.711 × 0.995age
|